Medicare Rx Means “Dramatic” Change For Pharma; CMS Is New FDA – Scully
Executive Summary
The Medicare drug benefit will make the Centers for Medicare & Medicaid Services at least as important to the pharmaceutical market as FDA, former CMS Administrator Tom Scully predicts
You may also be interested in...
CMS Influence Over Rx Industry Could Change Culture At FDA – Millennium
The increasing influence of the Centers for Medicare & Medicaid Services within the prescription drug industry could create opportunities for a "cultural shift" at FDA, Millennium Senior VP-R&D Strategy and Operations Abie Celniker said
CMS Influence Over Rx Industry Could Change Culture At FDA – Millennium
The increasing influence of the Centers for Medicare & Medicaid Services within the prescription drug industry could create opportunities for a "cultural shift" at FDA, Millennium Senior VP-R&D Strategy and Operations Abie Celniker said
Rx Industry Must Change “Mission” To Prepare For Medicare – Scully
The Medicare prescription drug benefit that begins in 2006 will fundamentally change the mission of pharmaceutical companies, former Centers for Medicare & Medicaid Services Administrator Tom Scully told the Washington Research Group's annual symposium in Washington, D.C. Nov. 5